Attention: Website ordering limitations

Sigma-Aldrich is currently experiencing a problem with our order management system. This impacts Africa, Europe, South America and most of Asia. During this time web ordering and real-time pricing and product availability are unavailable. Please contact your local Sigma-Aldrich office for assistance.

Order Center

Use the Order Center to build a Shopping Cart, view Saved Shopping Carts, Recent Orders and Quotes

MSDS

Search for MSDS (Material Safety Data Sheet) by Product Number

Oligo Ordering

Custom Products and Services, including DNA oligos (Primers and Probes), RNA, siRNA, Peptide Libraries and AQUA Peptides

Corporate

Sigma-Aldrich is a leading Life Science and High Technology Materials company focused on enabling science to improve the quality of life

Contáctenos

Contact Customer Service

Productos Regulados

Lista de productos controlados

Compra de Carbon Tetrachloride

Información importante acerca de la compra de Carbon Tetrachloride

VI Simposio CINVESTAV / SIGMA-ALDRICH

Visit Max's laboratory to amplify as many DNA fragments as possible to generate the correct base pairs

News & Information

St. Louis, MO - September 24, 2014 SAFC and Baxter BioPharma Solutions Collaborate on Complete ADC Offering

Sigma-Aldrich Corporation’s SAFC® Commercial custom manufacturing services business unit, and Baxter’s BioPharma Solutions business have established a collaborative manufacturing agreement. SAFC will contribute extensive expertise in conjugation and the manufacture of drug linkers, while BioPharma Solutions will offer world-class, sterile fill/finish services for final filling of ADC products.

Read More
St. Louis, MO - July 29, 2014 Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives

Sigma-Aldrich Corporation (NASDAQ: SIAL) dramatically decreased its global water and energy use, increased its investment in Green Chemistry and donated more than 8,000 hours of community service around the world last year, the Company announced Monday in its new 2013 Global Citizenship Report: What if Science Changed the World?

Read More
St. Louis, MO - June 30, 2014 Sigma-Aldrich CFO Jan Bertsch Named One of St. Louis’ Most Influential Business Women

Sigma-Aldrich Corporation (NASDAQ: SIAL) is proud to announce that Executive Vice President and Chief Financial Officer Jan Bertsch has been named one of St. Louis’ Most Influential Business Women by the St. Louis Business Journal.

Read More
St. Louis, MO - June 24, 2014 AGTC and SAFC Create Strategic Partnership to Provide Gene Therapy Manufacturing Services

Applied Genetic Technologies Corporation (NASDAQ: AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, and SAFC Commercial (SAFC), the Sigma-Aldrich Corporation (NASDAQ: SIAL) business unit that manufactures specialty chemicals and biologics for commercial life science applications, today announced that they signed an agreement to have SAFC provide gene therapy manufacturing services to companies developing gene-based therapies.

Read More